TELA · TELA BIO INC

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

1 Great Valley Parkway, Malvern, PA, 19355, United States
Medical Devices
Healthcare

Market Cap

48.75M

52 Wk Range

$0.50 - $1.56

Previous Close

$1.08

Open

$1.08

Volume

60,936

Day Range

$1.03 - $1.15

Enterprise Value

84.87M

Cash

30.42M

Avg Qtr Burn

-9.381M

Insider Ownership

7.11%

Institutional Own.

63.29%

Qtr Updated

Jun 30th 2026